Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients

被引：3
|
作者：
Guo, Qixiang [1 ]
Lu, Wenchao [1 ]
Sun, Ximu [2 ]
Zhao, Zhixia [1 ]
Liu, Lihong [3 ]
机构：
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pharm, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Pharm, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pharm, Beijing, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 157卷
关键词：
D O I：
10.1016/j.ejca.2021.08.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 360
页数：3
相关论文
共 50 条
  • [1] Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
    Ciciola, Paola
    Cascetta, Priscilla
    Bianco, Cataldo
    Formisano, Luigi
    Bianco, Roberto
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [2] Incidence of adrenal insufficiency in patients with solid malignancies treated with immune checkpoint inhibitors
    Archambault, Alexi
    Wang, Juan
    Byrne, Shauna
    Gullo, Giuseppe
    Hampp, Christian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 233 - 233
  • [3] Should we combine anti-angiogenic drugs and immune checkpoint inhibitors in RCC?
    Albertsen, Peter C.
    BJU INTERNATIONAL, 2021, 127 (01) : 28 - 29
  • [4] Primary adrenal insufficiency with immune checkpoint inhibitors
    Reactions Weekly, 2020, 1805 (1) : 11 - 11
  • [5] Checkpoint inhibitors and anti-angiogenic agents: a winning combination
    Brest, Patrick
    Mograbi, Baharia
    Pages, Gilles
    Hofman, Paul
    Milano, Gerard
    BRITISH JOURNAL OF CANCER, 2023, 129 (09) : 1367 - 1372
  • [6] Checkpoint inhibitors and anti-angiogenic agents: a winning combination
    Patrick Brest
    Baharia Mograbi
    Gilles Pagès
    Paul Hofman
    Gerard Milano
    British Journal of Cancer, 2023, 129 : 1367 - 1372
  • [7] Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
    Song, Yuxiao
    Fu, Yang
    Xie, Qi
    Zhu, Bo
    Wang, Jun
    Zhang, Bicheng
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] Primary Adrenal Insufficiency Secondary to Immune Checkpoint Inhibitors
    Bai, Joti
    Kohli, Jatinder
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 575 - 576
  • [9] bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy
    Xu, Gehan
    Cui, Liang
    Li, Jin
    Wang, Quanren
    Li, Pansong
    Xia, Xuefeng
    Yi, Xin
    Guan, Quanlin
    Xu, Jianming
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (10):
  • [10] Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?
    Granet-Vaissiere, Estelle
    Lefort, Felix
    Domblides, Charlotte
    Larroquette, Mathieu
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Gross-Goupil, Marine
    CANCERS, 2023, 15 (04)
12345